Jim Donovan Elected to the FNIH Board of Directors
Jim Donovan, Managing Director at Goldman Sachs, Elected to the Foundation for the National Institutes of Health’s Board of Directors
BETHESDA, MD, July 9, 2012 — Jim Donovan was unanimously elected to the Foundation for the National Institutes of Health (FNIH) Board of Directors. He began his term May 16, 2012.
Donovan has worked in investment banking, investment management and corporate strategy for nearly three decades. He also shares his expertise in the classrooms of the University of Virginia where he serves as an adjunct professor.
“Jim’s experience in investment banking is a great fit with the FNIH board of directors, adding significant depth in the business arena,” according to Charles A. Sanders, MD, FNIH chairman. “I welcome him to the board and look forward to working with him.”
“I deeply respect the role the FNIH plays in supporting the NIH’s commitment to improving health, and am honored by this appointment,” says Donovan. “I’ve been an advocate of cancer research in particular for many years, and I’m excited to help support efforts in its treatment and prevention. I hope my background, experience and knowledge will serve the FNIH well as it continues to build strong partnerships to advance the NIH mission.”
“I nominated Jim because of his experience in the medical field and his extensive financial background,” says Paul M. Montrone, PhD, FNIH board treasurer. “His work as a trustee of The Dana-Farber Cancer Institute will bring an added dimension to the FNIH board of directors.”
Among the board members’ responsibilities are helping guide the FNIH’s mission and purpose; ensuring effective organizational planning; ensuring adequate resources and managing them effectively; reviewing, monitoring, and strengthening FNIH’s programs and services; and enhancing FNIH’s public standing.
In total, eight people were elected to the FNIH Board of Directors this spring. They are: Paul Herrling, PhD; Ronald L. Krall, MD; Edison Liu, MD; Mr. Joel S. Marcus; Mr. Steven C. Mayer; Garry A. Neil, MD; and Mrs. Nina Solarz.
About the Foundation for the NIH
Established by the United States Congress to support the mission of the NIH — improving health through scientific discovery in the search for cure — the Foundation for the NIH is a leader in identifying and addressing complex scientific and health issues. The Foundation is a not-for-profit, 501(c)(3) charitable organization that raises private-sector funds for a broad portfolio of unique programs that complement and enhance the NIH priorities and activities. For additional information about the Foundation for the NIH, visit www.fnih.org.